Frederic H Moll is Director of PROCEPT BioRobotics Corp. Currently has a direct ownership of 809,609 shares of PRCT, which is worth approximately $58.8 Million. The most recent transaction as insider was on Jun 04, 2024, when has been sold 1,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 810K
0% 3M change
8.75% 12M change
Total Value Held $58.8 Million

FREDERIC H MOLL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
BUY
Grant, award, or other acquisition
-
1,376 Added 0.17%
809,609 Common Stock
Dec 06 2023
SELL
Open market or private sale
$3,070,730 $38.87 p/Share
79,000 Reduced 8.9%
808,233 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
2,711 Added 0.3%
887,233 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
$74,997 $37.48 p/Share
2,001 Added 0.23%
884,522 Common Stock
Sep 17 2021
BUY
Open market or private purchase
$10,000,000 $25.0 p/Share
400,000 Added 31.19%
882,521 Common Stock
Sep 17 2021
BUY
Conversion of derivative security
-
329,890 Added 40.61%
482,521 Common Stock

Also insider at

SWAV
Shockwave Medical, Inc. Healthcare
FHM

Frederic H Moll

Director
Santa Clara, CA

Track Institutional and Insider Activities on PRCT

Follow PROCEPT BioRobotics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT